Search
for
Sort by
Research 151–180 of 1000+
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Does a male polycystic ovarian syndrome equivalent exist?
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Androgen antagonists in androgen target tissues
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Adverse health effects of androgen use
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Is polycystic ovary syndrome a sexual conflict? A review
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Post-finasteride syndrome
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Alopecia Areata
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Androgenic alopecia: A counterproductive outcome of the anabolic effect of androgens
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Clinical Development of Topoisomerase-Interactive Drugs
- The Function of Zinc in Animal, Plant, and Human Nutrition
- Intrinsic versus Extrinsic Aging: A Histopathological, Morphometric and Immunohistochemical Study of Estrogen Receptor β and Androgen Receptor
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Androgenetic Alopecia
- Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 9 Days in Normal Men With Experimental Hypogonadism
- Hyperadrenocorticism in Ferrets
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results